FindTrial
Sign In

To compare two rectum separation methods during intracavitary brachytherapy treatment in cervical cancer

A Crossover trial to compare two rectum separation methods on organ at risk doses in high-dose rate intracavitary brachytherapy for cervical cancer with tandem-ring applicators.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/050059
Enrollment
52
Registered
2023-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

Intervention1: Rectal retractor blade with Radio-opaque vaginal packing in Tandem ring applicators: Intracavitory brachytherapy will be done using combination of rectal retractor with radio-opaque va

Sponsors

Principal IGMC Shimla
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Karnofsky status >70 normal biochemistry and biochemical profile IB to IV A stage no previous treatment

Exclusion criteria

Exclusion criteria: stage IA and IVA previously treated cases unfit for brachytherapy Karnofsky status

Design outcomes

Primary

MeasureTime frame
To compare the ICRU rectum point doses in RR alone and RR+ ROVP in patients of histopathological proven cervical cancer receiving intracavitary brachytherapy with tandem ring applicators. Timepoint: 2 year—

Secondary

MeasureTime frame
To compare the ICRU bladder point doses and dose volume parametersTimepoint: one year—

Countries

India

Contacts

Public ContactDr Siddharth Vats

Indira Gandhi Medical College Shimla

drsiddharthvats@gmail.com9418458100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026